Cancer Genomics And Diagnostics

145 researchers across 11 institutions

145 Researchers
11 Institutions
8 Grant PIs
25 High Impact

Cancer genomics and diagnostics research investigates the complex genetic and molecular underpinnings of cancer. Studies focus on identifying gene mutations, epigenetic alterations, and other genomic variations that drive cancer development and progression. Researchers employ advanced sequencing technologies, bioinformatics tools, and computational modeling to analyze tumor genomes and understand cancer heterogeneity. This work also encompasses the development and validation of novel diagnostic and prognostic biomarkers, aiming to improve early detection, personalize treatment strategies, and predict patient outcomes.

This research holds significant relevance for Arkansas. Understanding the genetic factors contributing to cancer prevalence and outcomes in the state's diverse populations can inform targeted public health initiatives and cancer prevention strategies. Furthermore, advancements in cancer diagnostics can support the growth of the state's biotechnology and healthcare sectors, fostering innovation and economic development. The focus on genomic analysis also aligns with the growing importance of precision medicine, enabling the development of more effective and tailored cancer therapies for Arkansans.

This area of study draws on expertise from molecular biology, bioinformatics, pathology, and computational science. Researchers across multiple Arkansas institutions collaborate to advance our understanding of cancer genomics and diagnostics, bridging fundamental biological discovery with clinical application.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Bart Barlogie UAMS 138 76,058 High Impact
John D. Shaughnessy UAMS 88 31,058 High Impact
Weida Tong NCTR 82 29,795
David M. Parham UAMS 81 21,060 High Impact
Shiv Srivastava UAMS 64 15,022 High Impact
Naveena Singh University of Arkansas – Fort Smith 64 16,943 High Impact
Vladimir P. Zharov UAMS 55 12,231 High Impact
David N. Church UAMS 45 9,282 High Impact
Christopher P. Wardell UAMS 36 7,505 High Impact
Charles M. Quick UAMS 35 3,892 High Impact
Peter D. Emanuel UAMS 32 3,535 Grant PI High Impact
Joshua Xu NCTR 31 5,849 High Impact
Erming Tian UAMS 31 5,369 High Impact
Mary Qu Yang UA Little Rock 30 5,179 High Impact
Thidathip Wongsurawat UAMS 29 2,835 High Impact
Barbara L. Parsons NCTR 29 2,850 High Impact
Mary A. Littrell UAMS 28 3,416 High Impact
Murat Gökden UAMS 27 2,908 Grant PI High Impact
Nicole Massoll UAMS 27 2,380 High Impact
Kathleen Neville UAMS 27 4,168 High Impact
Cancer-Related Molecular Mechanisms Research 46 Genomics And Phylogenetic Studies 43 Medical Imaging Techniques And Applications 39 Molecular Biology Techniques And Applications 36 Bioinformatics And Genomic Networks 36 Cancer Treatment And Pharmacology 24 Disease Mechanisms Research 23 Advanced Neural Network Applications 21 Ai In Cancer Detection 21 Health Sciences Research And Education 19 Radiomics And Machine Learning In Medical Imaging 17 Multiple Myeloma Research And Treatments 16 Immune Response And Inflammation 15 Health Disparities And Outcomes 15 Metabolism And Genetic Disorders 13

Connected Research Areas

Topics that share active collaborators with Cancer Genomics And Diagnostics in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
2 works in 2031
-49.2% CAGR 2018–2031
Leadership concentration
9.5% held by global top 5 institutions
Fragmented HHI 53
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2031 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 6,784
  2. 2 Harvard University 5,278
  3. 3 Memorial Sloan Kettering Cancer Center 5,248
  4. 4 Dana-Farber Cancer Institute 4,860
  5. 5 Johns Hopkins University 3,538

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Cancer Genomics And Diagnostics.

Peter DelNero UAMS
98%
Yue Zhao UA Little Rock
Mitch Brown University of Arkansas
96%
K. K. Wright Philander Smith College
Mitch Brown University of Arkansas
96%
Yue Zhao UA Little Rock
Mitch Brown University of Arkansas
94%
Peter DelNero UAMS
K. K. Wright Philander Smith College
94%
Yue Zhao UA Little Rock
K. K. Wright Philander Smith College
92%
Peter DelNero UAMS
Arthur Haut UAMS
74%
Yue Zhao UA Little Rock
Mitch Brown University of Arkansas
73%
Arthur Haut UAMS
K. K. Wright Philander Smith College
71%
Arthur Haut UAMS
Timothy Langford UAMS
70%
Yue Zhao UA Little Rock

Researchers with Federal Grants

Murat Gökden UAMS 2 grants Hu Jin University of Arkansas 2 grants Peter D. Emanuel UAMS 1 grant Jennifer Fowler Arkansas State University 1 grant Donald J. Johann UAMS 1 grant Qingfang He UA Little Rock 1 grant Joseph Andrews University of Arkansas 1 grant Jake Qualls Arkansas State University 1 grant
Browse All 145 Researchers in Directory